Scientific Advisory Board


Dr. Sekar Kathiresan (Chair)

Dr. Sekar Kathiresan is one of the world leaders in the genetics of heart disease. He is the director of preventive cardiology at Massachusetts General Hospital, an associate member in the Broad Institute’s Program in Medical and Population Genetics, and an associate professor of medicine at Harvard Medical School. He received his B.A. in history and graduated summa cum laude from the University of Pennsylvania in 1992. He received his M.D. from Harvard Medical School in 1997. Sekar completed his clinical training in internal medicine and cardiology at MGH and served as Chief Resident in Internal Medicine at MGH in 2002-2003. He pursued research training in cardiovascular genetics through a combined experience at the Framingham Heart Study and the Broad Institute of MIT and Harvard. In 2008, he joined the research faculties of the MGH Cardiovascular Research Center and the MGH Center for Human Genetic Research. In 2015 Sekar was selected by the National Institutes of Health to join a panel of experts formed to steer President Obama’s Precision Medicine Initiative.

Professor Nazneen Rahman

Professor Nazneen Rahman is Head of the Division of Genetics and Epidemiology at The Institute of Cancer Research and Head of the Cancer Genetics Clinical Unit at The Royal Marsden NHS Foundation Trust, where she also practises as a Consultant Clinical Geneticist. Professor Rahman qualified in medicine from Oxford University in 1991, and undertook her general medical training in Oxford and London. She completed a PhD in Molecular Genetics in 1999. In 2010, she was elected a Fellow of the Academy of Medical Sciences and, in 2016, she was appointed Commander of the Order of the British Empire (CBE) in recognition of her contribution to medical sciences.

In June 2017 AstraZeneca appointed Nazneen as a Non-executive Director and member of its Science Committee.

Professor Richard Trembath

Professor Richard Trembath presently holds the academic leadership position of Executive Dean of the Faculty of Life Sciences & Medicine at Kings College London. Prior to this, he was Vice-Principal for Health at Queen Mary University of London and Executive Dean of the Barts and The London School of Medicine and Dentistry, which he joined from the position of Head of Division of Genetics & Molecular Medicine, also at Kings College. He was also the founding Director of the National Institute for Health Research Comprehensive Biomedical Research Centre in association with Guy’s & St Thomas’ NHS Foundation Trust. Professor Trembath serves on Advisory and Editorial Boards and Committees of numerous national and international journals and academic societies. He is past President of The British Society of Human Genetics.

Professor Chas Bountra

Professor Chas Bountra is Chief Scientist at the Structural Genomics Consortium – a group of scientists focussed on using the latest genetic insights to identify new disease pathways and ultimately new targets for drug discovery. This scientific project is catalysed through ‘open’ collaborations with eight global pharmaceutical companies, several hundred academic labs, many patient groups and a number of SMEs, across the world. Within the University of Oxford, he is also Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and an Associate Member of the Department of Pharmacology, and he holds the post of Visiting Professor in Neuroscience and Mental Health at Imperial College, London.